Skip to main content
Clinical Trials/NCT05705999
NCT05705999
Recruiting
N/A

Strengthening Tourette Treatment OPtions Using TMS to Improve CBIT, a Double-blind, Randomized, Controlled Study

West Virginia University1 site in 1 country20 target enrollmentMarch 12, 2024

Overview

Phase
N/A
Intervention
Not specified
Conditions
Tourette Syndrome
Sponsor
West Virginia University
Enrollment
20
Locations
1
Primary Endpoint
Yale Global Tic Severity Scale (YGTSS)
Status
Recruiting
Last Updated
9 months ago

Overview

Brief Summary

This pilot study will investigate the clinical and neurophysiological effects of repetitive transcranial magnetic stimulation (rTMS) followed by comprehensive behavioral intervention for tics (CBIT) in adult patients with Tourette's Syndrome (TS). Two groups of moderate disease severity will be randomized to receive active or sham rTMS targeted to the supplementary motor area (SMA) followed by eight CBIT sessions. The change in tic frequency and severity (primary outcome) and neurophysiological changes (secondary outcome) will be compared between the two groups. The central hypothesis is that low frequency rTMS will augment the effects of CBIT through favorable priming of the SMA network.

Registry
clinicaltrials.gov
Start Date
March 12, 2024
End Date
December 30, 2026
Last Updated
9 months ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Jessica Frey

Assistant Professor

West Virginia University

Eligibility Criteria

Inclusion Criteria

  • Age 18 years or older
  • Diagnosis of Tourette Syndrome
  • Moderate Tic Severity at baseline

Exclusion Criteria

  • Presence of metallic objects or neurostimulators in the brain
  • Pregnancy
  • History of active seizures or epilepsy
  • Contraindications to receiving fMRI
  • Inability to participate in CBIT due to other underlying cognitive or medical condition

Outcomes

Primary Outcomes

Yale Global Tic Severity Scale (YGTSS)

Time Frame: Through study completion, an average of 3 months

Tic severity will be measured with YGTSS. YGTSS is a clinician-rated scale used to assess tic severity, scored out of 100 where a higher score indicates greater tic frequency and severity. It includes a checklist of motor and vocal tics followed by an assessment of the number, frequency, intensity, complexity, and inference of motor tics and phonic tics - scored separately. Each of these dimensions is scored on a 0 to 5 scale. The YGTSS provides three tic severity scores: Total Motor (0 to 25); Total Phonic (0 to 25) and the combined Total Tic Severity Score (0 to 50), as well as a separate Impairment dimension scored from 0 to 50.

Modified Rush Videotape Tic Rating Scale (mRVTRS)

Time Frame: Through study completion, an average of 3 months

This is a tool used by an objective examiner to quantify the severity of a patient's tics by rating the number of body areas affected, motor tic frequency, phonic tic frequency, motor tic severity, and phonic tic severity, each on a 0 through 4 score by watching a video of the patient. Scored out of 20, where a higher score indicates greater tic severity.

Study Sites (1)

Loading locations...

Similar Trials